Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2013, 14(1), 1370-1382; doi:10.3390/ijms14011370
Article

Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy

1,†
, 1,†
, 2
, 1
, 3
, 4
, 1
, 1
, 5,*  and 1,*
Received: 6 November 2012; in revised form: 25 December 2012 / Accepted: 25 December 2012 / Published: 11 January 2013
(This article belongs to the Special Issue Advances in Molecular Oncology)
View Full-Text   |   Download PDF [1888 KB, uploaded 19 June 2014]
Abstract: The traditional Chinese medicine bufalin, extracted from toad’s skin, has been demonstrated to exert anticancer activities in various kinds of human cancers. The mechanisms of action lie in its capacity to induce apoptosis, or termed type I programmed cell death (PCD). However, type II PCD, or autophagy, participates in cancer proliferation, progression, and relapse, as well. Recent studies on autophagy seem to be controversial because of the dual roles of autophagy in cancer survival and death. In good agreement with previous studies, we found that 100 nM bufalin induced extensive HepG2 cell apoptosis. However, we also noticed bufalin triggered autophagy and enhanced Beclin-1 expression, LC3-I to LC3-II conversion, as well as decreased p62 expression and mTOR signaling activation in HepG2 cells. Blockage of autophagy by selective inhibitor 3-MA decreased apoptotic ratio in bufalin-treated HepG2 cells, suggesting a proapoptotic role of bufalin-induced autophagy. Furthermore, we investigated the underlying mechanisms of bufalin-induced autophagy. Bufalin treatment dose-dependently promoted AMPK phosphorylation while AMPK inhibition by compound C significantly attenuated bufalin-induced autophagy. Taken together, we report for the first time that bufalin induces HepG2 cells PCD, especially for autophagy, and the mechanism of action is, at least in part, AMPK-mTOR dependent.
Keywords: hepatocellular carcinoma; bufalin; apoptosis; autophagy; AMPK; mTOR hepatocellular carcinoma; bufalin; apoptosis; autophagy; AMPK; mTOR
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Miao, Q.; Bi, L.-L.; Li, X.; Miao, S.; Zhang, J.; Zhang, S.; Yang, Q.; Xie, Y.-H.; Zhang, J.; Wang, S.-W. Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy. Int. J. Mol. Sci. 2013, 14, 1370-1382.

AMA Style

Miao Q, Bi L-L, Li X, Miao S, Zhang J, Zhang S, Yang Q, Xie Y-H, Zhang J, Wang S-W. Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy. International Journal of Molecular Sciences. 2013; 14(1):1370-1382.

Chicago/Turabian Style

Miao, Qing; Bi, Lin-Lin; Li, Xin; Miao, Shan; Zhang, Jin; Zhang, Song; Yang, Qian; Xie, Yan-Hua; Zhang, Jian; Wang, Si-Wang. 2013. "Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy." Int. J. Mol. Sci. 14, no. 1: 1370-1382.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert